Can antibodies keep HIV in check after stopping meds?
NCT ID NCT03526848
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 26 times
Summary
This early-stage study tested whether giving two lab-made antibodies (3BNC117 and 10-1074) to people with HIV could safely control the virus after they stopped their regular antiretroviral therapy. Twenty-six adults with well-controlled HIV took part. The goal was to see if these antibodies could delay or prevent the virus from rebounding, potentially offering a way to manage HIV without daily pills.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HUMAN IMMUNODEFICIENCY VIRUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ragon Institute of MGH, MIT, and Harvard
Boston, Massachusetts, 02114, United States
-
The Rockefeller University
New York, New York, 10065, United States
Conditions
Explore the condition pages connected to this study.